ATEC vs. IART, ATRC, OFIX, OSUR, TCMD, GMED, NARI, LMAT, TNDM, and NVCR
Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Integra LifeSciences (IART), AtriCure (ATRC), Orthofix Medical (OFIX), OraSure Technologies (OSUR), Tactile Systems Technology (TCMD), Globus Medical (GMED), Inari Medical (NARI), LeMaitre Vascular (LMAT), Tandem Diabetes Care (TNDM), and NovoCure (NVCR). These companies are all part of the "surgical & medical instruments" industry.
Integra LifeSciences (NASDAQ:IART) and Alphatec (NASDAQ:ATEC) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.
84.8% of Integra LifeSciences shares are held by institutional investors. Comparatively, 66.3% of Alphatec shares are held by institutional investors. 3.1% of Integra LifeSciences shares are held by company insiders. Comparatively, 29.1% of Alphatec shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Integra LifeSciences presently has a consensus target price of $44.89, suggesting a potential upside of 58.39%. Alphatec has a consensus target price of $23.63, suggesting a potential upside of 89.91%. Given Integra LifeSciences' stronger consensus rating and higher possible upside, analysts plainly believe Alphatec is more favorable than Integra LifeSciences.
Integra LifeSciences received 123 more outperform votes than Alphatec when rated by MarketBeat users. Likewise, 58.39% of users gave Integra LifeSciences an outperform vote while only 56.52% of users gave Alphatec an outperform vote.
Integra LifeSciences has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500.
Integra LifeSciences has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.
In the previous week, Alphatec had 1 more articles in the media than Integra LifeSciences. MarketBeat recorded 9 mentions for Alphatec and 8 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 0.39 beat Alphatec's score of 0.26 indicating that Alphatec is being referred to more favorably in the news media.
Integra LifeSciences has a net margin of 4.39% compared to Integra LifeSciences' net margin of -38.70%. Alphatec's return on equity of 15.19% beat Integra LifeSciences' return on equity.
Summary
Integra LifeSciences beats Alphatec on 10 of the 18 factors compared between the two stocks.
Get Alphatec News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alphatec Competitors List
Related Companies and Tools
